{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:55:45Z","timestamp":1792036545295,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["0063869"],"award-info":[{"award-number":["0063869"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Stiftelse","doi-asserted-by":"publisher","award":["M105\/19"],"award-info":[{"award-number":["M105\/19"]}],"id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019\u201301049"],"award-info":[{"award-number":["2019\u201301049"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmech.2023.115177","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T12:29:34Z","timestamp":1675254574000},"page":"115177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators"],"prefix":"10.1016","volume":"250","author":[{"given":"Amalyn","family":"Nain-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei","family":"Lulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"H\u00e5versen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Liljenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Hyv\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-4222","authenticated-orcid":false,"given":"Morten","family":"Gr\u00f8tli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115177_bib1","series-title":"Glycolysis","author":"Kumari","year":"2018"},{"key":"10.1016\/j.ejmech.2023.115177_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0079-6107(93)90001-Z","article-title":"Evolution of glycolysis","volume":"59","author":"Fothergill-Gilmore","year":"1993","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115177_bib3","series-title":"Encyclopedia of Cancer","first-page":"535","article-title":"Pyruvate kinases","author":"Weernink","year":"2002"},{"key":"10.1016\/j.ejmech.2023.115177_bib4","doi-asserted-by":"crossref","first-page":"18145","DOI":"10.1074\/jbc.M001870200","article-title":"The allosteric regulation of pyruvate kinase: a site-directed mutagenesis study","volume":"275","author":"Valentini","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115177_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(96)00462-0","article-title":"The allosteric regulation of pyruvate kinase","volume":"389","author":"Mattevi","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2023.115177_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0020-711X(78)90027-7","article-title":"Isozymes of pyruvate kinase in vertebrates: their physical, chemical, kinetic and immunological properties","volume":"9","author":"Wall","year":"1978","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.ejmech.2023.115177_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymben.2019.01.001","article-title":"Pyruvate kinase L\/R is a regulator of lipid metabolism and mitochondrial function","volume":"52","author":"Liu","year":"2019","journal-title":"Metab. Eng."},{"key":"10.1016\/j.ejmech.2023.115177_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.15252\/msb.20177703","article-title":"Network analyses identify liver\u2010specific targets for treating liver diseases","volume":"13","author":"Lee","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejmech.2023.115177_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jcmgh.2020.09.004","article-title":"Liver pyruvate kinase promotes NAFLD\/NASH in both mice and humans in a sex-specific manner","volume":"11","author":"Chella Krishnan","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2023.115177_bib10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2023.115177_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2023.115177_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114270","article-title":"Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase","volume":"234","author":"Nain-Perez","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115177_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-pharmtox-010611-134525","article-title":"Drugs for allosteric sites on receptors","volume":"54","author":"Wenthur","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2023.115177_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1107\/S2053230X19007209","article-title":"Changes in the allosteric site of human liver pyruvate kinase upon activator binding include the breakage of an intersubunit cation-\u03c0 bond","volume":"75","author":"McFarlane","year":"2019","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"10.1016\/j.ejmech.2023.115177_bib15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/jm901577g","article-title":"Evaluation of substituted N,N\u2032-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase","volume":"53","author":"Boxer","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115177_bib16","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1016\/j.bmc.2017.05.004","article-title":"Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator","volume":"25","author":"Matsui","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115177_bib17","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.bmcl.2010.04.015","article-title":"Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase","volume":"20","author":"Kang Jiang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115177_bib18","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1016\/j.bmcl.2011.08.114","article-title":"2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase","volume":"21","author":"Walsh","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115177_bib19","first-page":"1655","article-title":"Pyruvate kinase M2 at a glance","volume":"128","author":"Yang","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2023.115177_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.chembiol.2012.07.021","article-title":"Small molecule activation of pkm2 in cancer cells induces serine auxotrophy","volume":"19","author":"Kung","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115177_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3324\/haematol.2019.238865","article-title":"AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes","volume":"106","author":"Rab","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ejmech.2023.115177_bib23","article-title":"The potential and action mechanism of polyphenols in the treatment of liver diseases","author":"Li","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2023.115177_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/nu15030577","article-title":"Ellagic acid and its metabolites as potent and selective allosteric inhibitors of liver pyruvate kinase","volume":"15","author":"Battisti","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2023.115177_bib25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/jm901577g","article-title":"Evaluation of substituted N,N\u2032-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase","volume":"53","author":"Boxer","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115177_bib26","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1039\/D2NJ00088A","article-title":"Environmentally friendly catechol-based synthesis of dibenzosultams","volume":"46","author":"Liljenberg","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2023.115177_bib27","series-title":"Molecular Operating Environment (MOE)","author":"Chemical Computing Group","year":"2021"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:46:10Z","timestamp":1759329970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":26,"alternative-id":["S0223523423000922"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115177","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115177"}}